This research aims to improve outcomes for Intracerebral Haemorrhage (ICH) patients by developing new emergency treatments to reduce swelling in the brain after ICH, and improving the care that patients receive.
A haemorrhagic stroke is a stroke that is caused by bleeding in or around the brain. Although they are less common than strokes that are caused by a blockage, they can be much more serious.
This research will investigate 2000 drugs that are already known to be safe for use in humans to see if they could help reduce the amount of damage to the brain which an intracerebral haemorrhage (a type of stroke caused by a bleed in the brain) causes.
Dr Banerjee aims to set up three studies to improve our understanding of how damaging proteins in the brain may increase the risk of stroke. This can lead the way for researchers to find out how we can help more people avoid damage to their brain caused by these proteins.
The Stroke Association held a Haemorrhagic Stroke Workshop to set the priorities for haemorrhagic stroke research in the UK.
Intracerebral haemorrhage (ICH) is a type of stroke, which is caused by bleeding in the brain, ultimately leading to brain damage, disability and often death. We currently know very little about the biological changes that occur in the brain after intracerebral haemorrhage.
Resource type: Information leaflet
Publication type: Stroke information
Around 15% of strokes are haemorrhagic (due to bleeding in or around the brain). This guide explains the two different types of stroke caused by a bleed, intracerebral and subarachnoid haemorrhage, and how they are diagnosed and treated.
This research will find out if a new package of emergency treatments for stroke caused by bleeding in the brain, called the ‘ABC bundle’ can be used in hospitals across the UK.
People with stroke due to brain haemorrhage have swelling around the haemorrhage on their brain scan. More swelling worsens recovery. No treatment improves outcome after this swelling.
The programme will use biological information about cells and molecules, and information from patients, to design a study of treatment for swelling after a brain haemorrhage.